LinkedIn is the world’s largest professional social networking site, that allows over 830 million users from over 200 countries from a variety of industries to connect. As a result, it is a powerful tool used by professionals to network, collaborate,...
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...
1 April 2018
| Pippa Williams, Richard Bowman, Allen Foster (Prof), Ido Didi Fabian, Marcia Zondervan
|
EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...
1 October 2015
| David Tabibian, Farhad Hafezi
|
EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...
When I was a junior doctor in the late 1990s writing my first scientific papers, once each article was finished, I had to fill out an application form, print out multiple copies and then walk to the post office at...
5 June 2023
| Cameron R M Wilson, Ian Underwood, Baljean Dhillon (Prof)
|
EYE - Vitreo-Retinal
A new virtual reality application visually simulates age-related macular degeneration and demonstrates its progression over time including some Charles Bonnet syndrome hallucinations. Introduction Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries with the prevalence of...
In partnership with The Royal College of Ophthalmologists, Fight for Sight is now inviting applications for its John Lee Primer Fellowships, offering up to £60,000 to support early career ophthalmologists to undertake ground-breaking vision research.
The Qatar Fund for Development (QFFD) are providing funding to international eye care charity Orbis, to launch the Qatar Creating Vision initiative Ethiopia.
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
In November, a full-day course was run at the RCOphth in London to introduce basic training in ophthalmic ultrasound. The faculty on the course were: Mr Hatem Atta, Mr Tarek El Kashab and Dr Peter Good.